Septal Occluder Prevents Recurrent Ischemic Stroke
|
By HospiMedica International staff writers Posted on 11 Apr 2018 |

Image: A lightweight occluder closes defects in the heart (Photo courtesy of Gore).
An innovative occlusion device facilitates permanent closure of atrial septal defects (ASD) and patent foramen ovale (PFO), including challenging defects.
The Gore Medical Products (Gore; Flagstaff, AZ, USA) Cardioform Septal Occluder is a transcatheter-delivered device comprised of two independent conformable discs that span and cover the heart's anatomy to close defects. Each disc consists of a platinum-filled nitinol wire frame covered with a thin expanded polytetrafluoroethylene (ePTFE) membrane coated with a hydrophilic surface treatment (facilitating echocardiographic imaging). When fully deployed, the Occluder assumes a double-disc configuration to prevent shunting of blood through the defect.
The delivery system consists of a 75 cm working length 10 Fr catheter that is coupled to a handle that facilitates loading, deployment, and locking of the Occluder; the handle also allows repositioning and retrieval, if necessary. The Occluder is available in diameters of 15, 20, 25, and 30 mm, and can be used to close defects of up to 17 mm. Once in position, the Occluder provides optimal apposition to the surrounding anatomy for immediate closure, together with rapid endothelialization and lasting long-term performance.
“The soft and conformable design of Gore's device is ideal for providing long-term repair of PFOs of any shunt size,” said John Rhodes, MD, of the Medical University of South Carolina (MUSC; Charleston, USA). “I am pleased that a device I have grown to trust for ASD closure is now FDA approved for PFO closure as well. The clear reduction in recurrent ischemic stroke provided by PFO closure far outweighs the low risk of serious adverse events.”
When the chambers of a human heart begin to develop, a tunnel is formed between the right and left atria of the heart in order to allow blood to flow directly from the venous to the arterial circulation, circumventing the non-functioning fetal lungs. Following birth, a pressure differential between the right and left atria forms to allow blood flow to the fully functioning lungs, and the tunnel eventually closes completely. When this does not occur, a PFO is formed, allowing blood clots and deoxygenated blood to cross over to the arterial side.
Related Links:
Gore Medical Products
The Gore Medical Products (Gore; Flagstaff, AZ, USA) Cardioform Septal Occluder is a transcatheter-delivered device comprised of two independent conformable discs that span and cover the heart's anatomy to close defects. Each disc consists of a platinum-filled nitinol wire frame covered with a thin expanded polytetrafluoroethylene (ePTFE) membrane coated with a hydrophilic surface treatment (facilitating echocardiographic imaging). When fully deployed, the Occluder assumes a double-disc configuration to prevent shunting of blood through the defect.
The delivery system consists of a 75 cm working length 10 Fr catheter that is coupled to a handle that facilitates loading, deployment, and locking of the Occluder; the handle also allows repositioning and retrieval, if necessary. The Occluder is available in diameters of 15, 20, 25, and 30 mm, and can be used to close defects of up to 17 mm. Once in position, the Occluder provides optimal apposition to the surrounding anatomy for immediate closure, together with rapid endothelialization and lasting long-term performance.
“The soft and conformable design of Gore's device is ideal for providing long-term repair of PFOs of any shunt size,” said John Rhodes, MD, of the Medical University of South Carolina (MUSC; Charleston, USA). “I am pleased that a device I have grown to trust for ASD closure is now FDA approved for PFO closure as well. The clear reduction in recurrent ischemic stroke provided by PFO closure far outweighs the low risk of serious adverse events.”
When the chambers of a human heart begin to develop, a tunnel is formed between the right and left atria of the heart in order to allow blood to flow directly from the venous to the arterial circulation, circumventing the non-functioning fetal lungs. Following birth, a pressure differential between the right and left atria forms to allow blood flow to the fully functioning lungs, and the tunnel eventually closes completely. When this does not occur, a PFO is formed, allowing blood clots and deoxygenated blood to cross over to the arterial side.
Related Links:
Gore Medical Products
Latest Surgical Techniques News
- Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
Channels
Critical Care
view channel
Ingestible Capsule Monitors Intestinal Inflammation
Acute mesenteric ischemia—a life-threatening condition caused by blocked blood flow to the intestines—remains difficult to diagnose early because its symptoms often mimic common digestive problems.... Read more
Wireless Implantable Sensor Enables Continuous Endoleak Monitoring
Endovascular aneurysm repair (EVAR) is a life-saving, minimally invasive treatment for abdominal aortic aneurysms—balloon-like bulges in the aorta that can rupture with fatal consequences.... Read more
Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
Skin cancer remains one of the most dangerous and common cancers worldwide, with early detection crucial for improving survival rates. Traditional diagnostic methods—visual inspections, imaging, and biopsies—can... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







